132 related articles for article (PubMed ID: 26449138)
1. Ancient Gunpowder and Novel Insights Team Up Against Heart Failure With Preserved Ejection Fraction.
Paulus WJ; van Heerebeek L
J Am Coll Cardiol; 2015 Oct; 66(15):1683-6. PubMed ID: 26449138
[No Abstract] [Full Text] [Related]
2. Nitrites/Nitrates in Heart Failure With Preserved Ejection Fraction.
Weber T; Eber B; Wassertheurer S; Hametner B; O'Rourke MF
J Am Coll Cardiol; 2016 Mar; 67(11):1382-3. PubMed ID: 26988965
[No Abstract] [Full Text] [Related]
3. Reply: Nitrites/Nitrates in Heart Failure With Preserved Ejection Fraction.
Borlaug BA; Koepp KE; Melenovsky V
J Am Coll Cardiol; 2016 Mar; 67(11):1383-4. PubMed ID: 26988966
[No Abstract] [Full Text] [Related]
4. Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction.
Borlaug BA; Koepp KE; Melenovsky V
J Am Coll Cardiol; 2015 Oct; 66(15):1672-82. PubMed ID: 26449137
[TBL] [Abstract][Full Text] [Related]
5. Relationship of loop diuretic use with exercise intolerance in heart failure with preserved ejection fraction.
Montero D; Haider T
Eur Heart J Cardiovasc Pharmacother; 2018 Jul; 4(3):138-141. PubMed ID: 29319788
[No Abstract] [Full Text] [Related]
6. INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and Design.
Reddy YNV; Lewis GD; Shah SJ; LeWinter M; Semigran M; Davila-Roman VG; Anstrom K; Hernandez A; Braunwald E; Redfield MM; Borlaug BA
Circ Heart Fail; 2017 May; 10(5):. PubMed ID: 28476756
[TBL] [Abstract][Full Text] [Related]
7. Abnormal adrenergic activation is the major determinant of reduced functional capacity in heart failure with preserved ejection fraction.
Messias LR; Messias AC; de Miranda SM; Wiefels CC; Ferreira AG; Santos LM; Teixeira JA; Marostica E; Mesquita CT
Int J Cardiol; 2016 Jan; 203():900-2. PubMed ID: 26609687
[No Abstract] [Full Text] [Related]
8. Nitrite therapy improves left ventricular function during heart failure via restoration of nitric oxide-mediated cytoprotective signaling.
Bhushan S; Kondo K; Polhemus DJ; Otsuka H; Nicholson CK; Tao YX; Huang H; Georgiopoulou VV; Murohara T; Calvert JW; Butler J; Lefer DJ
Circ Res; 2014 Apr; 114(8):1281-91. PubMed ID: 24599803
[TBL] [Abstract][Full Text] [Related]
9. Harnessing the nitrate-nitrite-nitric oxide pathway for therapy of heart failure with preserved ejection fraction.
Vanderpool R; Gladwin MT
Circulation; 2015 Jan; 131(4):334-6. PubMed ID: 25533965
[No Abstract] [Full Text] [Related]
10. Effect of inorganic nitrate on exercise capacity in heart failure with preserved ejection fraction.
Zamani P; Rawat D; Shiva-Kumar P; Geraci S; Bhuva R; Konda P; Doulias PT; Ischiropoulos H; Townsend RR; Margulies KB; Cappola TP; Poole DC; Chirinos JA
Circulation; 2015 Jan; 131(4):371-80; discussion 380. PubMed ID: 25533966
[TBL] [Abstract][Full Text] [Related]
11. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
[TBL] [Abstract][Full Text] [Related]
12. Inhaled Sodium Nitrite Improves Rest and Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction.
Borlaug BA; Melenovsky V; Koepp KE
Circ Res; 2016 Sep; 119(7):880-6. PubMed ID: 27458234
[TBL] [Abstract][Full Text] [Related]
13. The Nitrate-Nitrite-NO Pathway and Its Implications for Heart Failure and Preserved Ejection Fraction.
Chirinos JA; Zamani P
Curr Heart Fail Rep; 2016 Feb; 13(1):47-59. PubMed ID: 26792295
[TBL] [Abstract][Full Text] [Related]
14. Heart failure with preserved ejection fraction: controversies, challenges and future directions.
Zakeri R; Cowie MR
Heart; 2018 Mar; 104(5):377-384. PubMed ID: 29305560
[TBL] [Abstract][Full Text] [Related]
15. Treating heart failure with preserved ejection fraction: statins could make the difference.
Athyros VG; Katsiki N; Karagiannis A
Angiology; 2014 Apr; 65(4):328-9. PubMed ID: 24202663
[No Abstract] [Full Text] [Related]
16. Nitrate's effect on activity tolerance in heart failure with preserved ejection fraction trial: rationale and design.
Zakeri R; Levine JA; Koepp GA; Borlaug BA; Chirinos JA; LeWinter M; VanBuren P; Dávila-Román VG; de Las Fuentes L; Khazanie P; Hernandez A; Anstrom K; Redfield MM
Circ Heart Fail; 2015 Jan; 8(1):221-8. PubMed ID: 25605640
[No Abstract] [Full Text] [Related]
17. Surrogate end points in heart failure trials.
Gheorghiade M; Adams KF; Gattis WA; Teerlink JR; Orlandi C; O'Connor CM
Am Heart J; 2003 Feb; 145(2 Suppl):S67-70. PubMed ID: 12594457
[No Abstract] [Full Text] [Related]
18. Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction.
Zile MR; Bourge RC; Redfield MM; Zhou D; Baicu CF; Little WC
JACC Heart Fail; 2014 Apr; 2(2):123-30. PubMed ID: 24720918
[TBL] [Abstract][Full Text] [Related]
19. Exercise Intolerance In Heart Failure With Preserved Ejection Fraction.
Gupte AA; Hamilton DJ
Methodist Debakey Cardiovasc J; 2016; 12(2):105-9. PubMed ID: 27486493
[TBL] [Abstract][Full Text] [Related]
20. Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy.
Nodari S; Triggiani M; Campia U; Manerba A; Milesi G; Cesana BM; Gheorghiade M; Dei Cas L
J Am Coll Cardiol; 2011 Feb; 57(7):870-9. PubMed ID: 21215550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
